She weighs whether the pop-up clinics spreading lately are a good thing for weight loss patients and for medicine overall.
Recap by typeshit. Post by @dr.alo on Instagram.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
29:53
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
Kalkine ties the Canadian-listed company's move to its peptide therapy push, fresh funding and interest in the longevity market.
The Warrington Guardian reports charges against staff over the theft of weight-loss injections valued at around £20,000.
Loading…